# US 7,611,453 B2 · Apparatus and method for static magnetic field treatment of tissue, organs, cells, and molecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,611,453 B2
- Document ID: US7611453B2
- Status: Granted
- Kind: B2
- Application number: 11/009,878
- Filed: 2004-12-11
- Published: 2005-09-29
- Granted: 2009-11-03
- Earliest claimed: 2003-12-12
- Inventors: Arthur A. Pilla; David John Muehsam; Charles Zablotsky; Ted Zablotsky
- Web page: https://patentgrep.com/patent/US7611453B2

## CPC

- A61N 2/008: {for pain treatment or analgesia}
- A61N 2/06: using magnetic fields produced by permanent magnets (A61N2/12 takes precedence)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

An apparatus and method for static magnetic field treatment of plants, animals, and humans comprising the steps of configuring at least one composite static magnetic field by combining at least one of a bipolar static magnetic field and an axial static magnetic field, optimizing spatial distribution and amplitude of the composite static magnetic field at a target pathway structure by satisfying a mathematical model, and coupling the at least one optimized composite static magnetic field to the target pathway structure using a composite static magnetic device.

## Claims

### Claim 1

A method for static magnetic field treatment of plants, animals, and humans comprising the steps of:
configuring at least one composite static magnetic field by combining at least one of a bipolar static magnetic field and an axial static magnetic field;
optimizing spatial distribution and amplitude of said composite static magnetic field at a target pathway structure by satisfying a mathematical model wherein said mathematical model includes a Larmor precession model; and
coupling said at least one optimized composite static magnetic field to said target pathway structure using a composite static magnetic device.

### Claim 2 (depends on 1)

The method of claim 1, wherein said step of optimizing spatial distribution and amplitude of said composite static magnetic field further comprises optimizing a peak composite static magnetic field to be between about 0.1 G and about 5000 G.

### Claim 3 (depends on 1)

The method of claim 1, wherein said step of optimizing spatial distribution and amplitude of said composite static magnetic field further comprises optimizing a composite static magnetic field gradient to be between about 0.1 G/mm and about 106 G/mm.

### Claim 4 (depends on 1)

The method of claim 1, wherein said step of optimizing spatial distribution and amplitude of said composite static magnetic field further comprises optimizing a composite static magnetic field gradient to be between about 0.1 G/mm and about 106 G/mm, whereby said composite static magnetic field gradient is applied to a treatment volume of at least about 0.1 mm3.

### Claim 5 (depends on 1)

The method of claim 1, wherein said step of optimizing spatial distribution and amplitude of said composite static magnetic field further comprises optimizing a peak composite static magnetic field to be between about 0.1 G and about 5000 G, whereby said peak composite static magnetic field is applied to a treatment volume of at least about 0.1 mm3.

### Claim 6 (depends on 1)

The method of claim 1, wherein said target pathway structure includes at least one of a molecule, a cell, a tissue and an organ.

### Claim 7 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to reduce pain.

### Claim 8 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to reduce edema.

### Claim 9 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to enhance healing.

### Claim 10 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to enhance wellbeing.

### Claim 11 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to use in combination with at least one of standard and nonstandard medical therapies.

### Claim 12 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises coupling said at least one optimized composite static magnetic field to use in combination with at least one of standard and nonstandard physical therapies.

### Claim 13 (depends on 1)

The method of claim 1, wherein said step of coupling said at least one optimized composite static magnetic field further comprises using a positioning device to deliver for treatment said at least one optimized composite static magnetic field to said target pathway structure.

### Claim 14 (depends on 13)

The method of claim 13, wherein said positioning device includes at least one of anatomical supports, anatomical wraps, mattresses, mattress pads, pillows, and apparel.

### Claim 15 (depends on 14)

The method of claim 14, wherein said apparel includes garments, fashion accessories, and footwear.
